arrow
J

Jonathan D. Casey

Johns Hopkins Bloomberg School of Public Health
H指数:49
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Induction Agents for Tracheal Intubation of Critically Ill Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

危重症患者气管插管诱导剂:随机对照试验的系统评价和网络荟萃分析

Chest
IF8.6
2026-08-180
OAAI
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial

恩塞特雷韦治疗住院成人COVID-19:一项国际多中心III期随机安慰剂对照试验

2026-04-220
PRE
Response

响应

CHEST
IF8.6
2025-10-080
PRE
Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023

2022年10月至2023年9月美国中田纳西州成人RSV相关住院发生率

2025-08-250
OAAI
Association Between Operator Experience and Procedural Outcomes of Tracheal Intubation in the Emergency Department and ICU

急诊科和ICU气管插管操作结果与操作者经验之间的关系

2025-08-230
PRE
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus

成人呼吸道合胞病毒感染的多重共病模式与院内严重预后

2025-08-010
PRE
Oxygen Saturation Targets and Neurologic Outcomes Following Cardiac Arrest

心脏骤停后血氧饱和度目标与神经功能结局

CHEST
IF8.6
2025-04-300
OAAI
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill

循证个体化重症医学:量化并应用于危重患者个体化治疗效应的框架

2025-04-150
PRE
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024

疫苗对流感A(H1N1)、A(H3N2)和B相关住院的效力,美国,2023年9月1日至2024年5月31日

2025-04-080
PRE
Low-Intensity vs Moderate-Intensity Anticoagulation for Venovenous Extracorporeal Membrane Oxygenation

低强度与中强度抗凝在静脉-静脉体外膜氧合中的应用比较

CHEST
IF8.6
2025-03-110
PRE
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials
2025-01-010
OAAI